Kesios Therapeutics kesios.com


Kesios Therapeutics is developing novel therapeutics for the treatment of multiple myeloma and other cancers. KES-0001, the company's lead drug candidate, is about to enter clinical studies as a potential treatment for multiple myeloma.

Kesios Therapeutics is developing novel therapeutics for the treatment of multiple myeloma and other cancers. KES-0001, the company's lead drug candidate, is about to enter clinical studies as a potential treatment for multiple myeloma.

Company (Alive / Active)

Phone: +44 (0) 203 818 9280

Fax:

Bessemer Building Levels 1 & 2

London, SW7 2AZ
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Kesios Therapeutics $31.4M Dec 2, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Kesios Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)